Table 3.

Association of abdominal obesity-MAFLD with risk of kidney disease-related mortality.

kidney disease-related mortality	Univariable model		Multivariable Model 1		Multivariable Model 2		Multivariable model 3
	HR(95%CI)	p	HR(95%CI)	p	HR(95%CI)	p	HR(95%CI)	p
Group 1	1(reference)		1(reference)		1(reference)		1(reference)
Group 2	1.716(0.400–7.365)	0.468	1.730(0.378–7.922)	0.480	1.599(0.356–7.186)	0.541	1.788(0.391–8.185)	0.454
Group 3	2.358(0.803–6.923)	0.119	2.485(0.837–7.377))	0.101	2.126(0.715–6.321)	0.175	1.348(0.414–4.394)	0.620
Group 4	5.316(2.031–13.913)	0.001	5.617(2.090–15.098)	0.001	4.646(1.698–12.712)	0.003	3.448(1.058–11.239)	0.040

HR, hazard ratio; CI, confidence interval.

Model 1 was adjusted for: age, sex, race.

Model 2 was adjusted for model 1 plus marital status, military service, sedentary behavior.

Model 3 was further adjusted for model 2 plus weight category by BMI, advanced fibrosis by NFS, proteinuria, LDL, TG, Tc, albumin.